- Home
- FORA
FORA
Forian Inc.
as 12-18-2024 10:37am EST
Forian Inc provides a suite of Software, data management capabilities, and proprietary data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer, and provider segments, as well as cannabis dispensaries, manufacturers, and cultivators.
| Founded: | 2014 | Country: | United States |
| Employees: | N/A | City: | NEWTOWN |
| Market Cap: | 63.8M | IPO Year: | N/A |
| Target Price: | $5.00 | AVG Volume (30 days): | 17.1K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.09 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.97 - $4.15 | Next Earning Date: | 11-13-2024 |
| Revenue: | $19,709,723 | Revenue Growth: | -1.85% |
| Revenue Growth (this year): | -1.84% | Revenue Growth (next year): | 13.59% |
Latest Forian Inc. News
FORA Breaking Stock News: Dive into FORA Ticker-Specific Updates for Smart Investing
GlobeNewswire
2 days ago
Forian Partners With Databricks to Expand Access to Advanced Healthcare Analytics
Simply Wall St.
a month ago
Forian Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
GuruFocus.com
a month ago
Forian Inc (FORA) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ...
GlobeNewswire
a month ago
Forian Inc. Announces Third Quarter 2024 Financial Results
GlobeNewswire
a month ago
Forian Inc. to Participate in the 13th Annual ROTH MKM Technology Event
GlobeNewswire
a month ago
Forian Inc. to Announce Third Quarter 2024 Results on November 13, 2024
GlobeNewswire
2 months ago
Forian Acquires Kyber Data Science to Enhance Data Analytics Capabilities
GlobeNewswire
4 months ago
Forian Inc. Announces Second Quarter 2024 Financial Results
Compare FORA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "FORA Forian Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.